Wip-ing out cancer.
Open Access
- 1 April 2004
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 36 (4) , 319-320
- https://doi.org/10.1038/ng0404-319
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK–mediated activation of the p16Ink4a-p19Arf pathwayNature Genetics, 2004
- Turning the key on p53Nature, 2004
- Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23Nature Genetics, 2002
- Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activityNature Genetics, 2002
- Perspectives on the development of a molecularly targeted agentCancer Cell, 2002
- Mice Deficient for the Wild-Type p53-Induced Phosphatase Gene (Wip1) Exhibit Defects in Reproductive Organs, Immune Function, and Cell Cycle ControlMolecular and Cellular Biology, 2002
- Specific protection against breast cancers by cyclin D1 ablationNature, 2001
- Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinaseNature, 2001
- p53-inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiationThe EMBO Journal, 2000
- Cyclin D1 Expression Is Regulated Positively by the p42/p44 and Negatively by the p38/HOG PathwayJournal of Biological Chemistry, 1996